Fatal Outcome of Disseminated Strongyloidiasis despite Detectable Plasma and Cerebrospinal Levels of Orally Administered Ivermectin.
Strongyloides stercoralis affects over 100 million people worldwide. Those people most susceptible to infection are those with an immunocompromising condition, such as cancer or human immunodeficiency virus (HIV). Local disease may spread throughout the body of the host, causing a condition termed disseminated strongyloidiasis. Standard treatment for Strongyloides stercoralis infection is oral ivermectin. We describe a patient with chronic lymphocytic leukemia diagnosed with disseminated strongyloidiasis two weeks after initial presentation. After repeated dosing of oral ivermectin with no clinical response, serum and cerebral spinal fluid (CSF) concentrations of ivermectin were measured to assess absorption. The peak serum concentration of 49.3 ng/mL correlated with a CSF concentration of 0.14 ng/mL. Despite these concentrations, the patient eventually succumbed to multi-system organ failure. We discuss the reasons for treatment failure and explore the utility of measuring ivermectin concentrations.
Rose
Charles E
CE
Lexington Infectious Disease Consultants, Lexington, KY 40503, USA.
Paciullo
Christopher A
CA
Kelly
David R
DR
Dougherty
Mark J
MJ
Fleckenstein
Lawrence L
LL
Clin Infect Dis. 2001 Oct 1;33(7):1040-7
11528578
Am J Trop Med Hyg. 1996 Nov;55(5):477-81
8940976
Am J Trop Med Hyg. 1987 Jul;37(1):157-61
3605497
Rev Infect Dis. 1981 May-Jun;3(3):397-407
7025145
N Engl J Med. 1966 Nov 17;275(20):1093-6
5925209
Am J Med. 1973 Dec;55(6):832-8
4800567
Trans R Soc Trop Med Hyg. 1996 Nov-Dec;90(6):702-3
9015524
Lancet. 2000 Jan 1;355(9197):43-4
10615895
J Pharm Biomed Anal. 2006 Mar 3;40(4):1013-20
16242280
Infection. 2005 Oct;33(5-6):383-6
16258873
Am J Trop Med Hyg. 1999 Jan;60(1):146-9
9988339
Clin Infect Dis. 2000 Sep;31(3):E5-6
11017858
J Clin Pharmacol. 2002 Oct;42(10):1122-33
12362927
Clin Infect Dis. 1993 Nov;17(5):900-2
8286637
Am J Trop Med Hyg. 2005 Nov;73(5):911-4
16282302
Am J Epidemiol. 1990 Aug;132(2):257-64
2196791
Am J Trop Med Hyg. 2005 Jul;73(1):122-4
16014846
Curr Opin Infect Dis. 2006 Dec;19(6):588-93
17075336
Clin Microbiol Rev. 2004 Jan;17(1):208-17
14726461
Am J Trop Med Hyg. 1998 Oct;59(4):535-8
9790425
Intern Med. 2000 Sep;39(9):695-700
10969899
Ann Pharmacother. 2007 Dec;41(12):1992-2001
17940124
Clin Infect Dis. 2005 Apr 1;40(7):1005-15
15824993
Adv Parasitol. 1999;42:277-341
10050275
Clin Infect Dis. 2005 Jul 1;41(1):e5-8
15937753